💨 Abstract

Becton Dickinson and Co. reported a higher-than-expected Q2 earnings of $3.35 per share, though revenue fell short of estimates. The medical device manufacturer anticipates full-year earnings of $14.06-$14.34 per share and revenue of $21.8-$21.9 billion. Despite this, the company's shares have decreased nearly 9% since the start of the year.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖